TAP polymorphisms in Swedish myasthenia gravis patients

Area of Science:

• Immunogenetics
• Neuromuscular Diseases

Background:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• The role of human leukocyte antigen (HLA) and related genes, such as the transporter associated with antigen processing (TAP), in MG pathogenesis is under investigation.
• Previous studies suggest associations between certain HLA alleles (DQ2, DR3) and MG susceptibility.

Purpose of the Study:

• To investigate the association between polymorphisms in the TAP1 and TAP2 genes and myasthenia gravis (MG) in a Swedish population.
• To determine if any observed associations between TAP alleles and MG are independent of linkage disequilibrium with DQ2 and DR3.
• To explore potential differences in TAP allele associations based on disease onset and DQ2 status.

Main Methods:

• Case-control study involving 79 Swedish MG patients and 155 unrelated controls.
• TAP typing was performed using the Amplification Refractory Mutation System - Polymerase Chain Reaction (ARMS-PCR) technique.
• Stratification analysis was employed to assess independence from DQ2 and DR3 alleles.

Main Results:

• No independent risk for MG was conferred by TAP1 or TAP2 alleles.
• The TAP2*0101 allele showed a positive association with MG specifically in patients with early-onset disease compared to late-onset disease.
• TAP1 and TAP2 alleles did not confer risk in MG patients who were negative for the DQ2 allele.

Conclusions:

• Susceptibility to myasthenia gravis is not primarily conferred by TAP alleles within the extended DR3 haplotype.
• The TAP2*0101 allele may play a role in the development of early-onset myasthenia gravis, potentially through mechanisms independent of DQ2.
• Further research is needed to elucidate the complex genetic underpinnings of myasthenia gravis.